FDA Inspection 1334834 — Chang Ki Min, MD, PhD

Chang Ki Min, MD, PhD — FEI 3044737954

The FDA completed an inspection of Chang Ki Min, MD, PhD on Jul 31, 2026 in Banpo-Daero, Seocho. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 31, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Banpo-Daero, Seocho (Korea (the Republic of))

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.